Loading...

Immunic, Inc.

IMUX•NASDAQ
Healthcare
Biotechnology
$9.95
$9.03(983.52%)
U.S. Market is Open • 12:00

Immunic, Inc. (IMUX) Stock Overview

Explore Immunic, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap86.9M
P/E Ratio-14.11
EPS (TTM)$-0.62
ROE-11.98%
Fundamental Analysis

AI Price Forecasts

1 Month$1.01
3 Months$0.84
1 Year Target$0.36

IMUX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immunic, Inc. (IMUX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.11 and a market capitalization of 86.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.16%
5-Day Change
-11.99%
1-Month Change
-29.59%
3-Month Change
28.05%
6-Month Change
14.67%
Year-to-Date (YTD) Change
64.91%
1-Year Change
-22.80%
3-Year Change
-42.10%
5-Year Change
-94.12%
All-Time (Max) Change
-99.82%

Contact Information

https://www.immunic-therapeutics.com
332 255 9818
1200 Avenue of the Americas, New York City, NY, 10036

Company Facts

91 Employees
IPO DateApr 17, 2014
CountryUS
Actively Trading

Frequently Asked Questions